Convergence is designed, programmed, and run by a group of people who are committed to the life sciences sector. The Advisory Board for Convergence includes:

Safi Bahcall, PhD - President and CEO, Synta Pharmaceuticals  

Ansbert Gadicke, MD - Managing Director, MPM Capital

Shayne Gilbert - Founder, Silverweave; author of 90 Days to Launch 

Michael Hanewich - Head of Life Sciences, Silicon Valley Bank

Scott Kirsner - Innovation Economy columnist, Boston Globe

Rich Kivel - CEO, TheraGenetics, Ltd.

Maggie Flanagan Leflore, PhD - Managing Director, MedImmune Ventures, Inc., AstraZeneca

Douglas MacDougall - President, MacDougall Biomedical 
Communications, Inc.

Una Ryan, PhD, OBE - former President and CEO, AVANT Immunotherapeutics, Inc.

Bruce Rychlik - Managing Director, Life Sciences, J. Robert Scott

Alyssa Stern - Vice President, Future Forward Events LLC

Alison Taunton-Rigby, PhD, OBE - CEO, RiboNovix, Inc.

Advisors Emeritus

Joseph Baron - General Partner, Extera Partners LLC

Frank Moss, PhD - Cofounder, Infinity Pharmaceuticals; Director, MIT Media Lab

Jonathan Rosen, PhD - Executive Director, Institute for Technology Entrepreneurship and Commercialization (ITEC), Boston University School of Management; Senior Advisor to the Director, CIMIT

John Santini, PhD - President and CEO, MicroCHIPS, Inc.

Scott Sarazen - Global Biotechnology Markets Leader, Ernst & Young

Andrey Zarur, PhD - CEO, BioProcessors